Oslo, April 16 -- : A day after Denmark's decision to abandon the AstraZeneca COVID vaccine over links with very rare blood clots, Norway's public health institute on Thursday said the country should stop using it.
Both the World Health Organization and the European Medicines Agency have said the benefits of the vaccine outweigh its risks, reported euronews.
"There is now significantly more knowledge about the connection between the AstraZeneca vaccine and the rare and serious incidents of low platelets, blood clots and bleeding than when Norway chose to put further use of the AstraZeneca vaccine on pause in March," said Geir Bukholm, director of infection control at Norway's National Institute of Public Health.
"Based on this knowledge,...